Vicarious Surgical Raises An Additional $13.2 Mil in Capital

IN.PACT AV Drug-Coated Balloon Is First and Only to Show Superior and Sustained Results Through Two Years Compared to PTA in Treating Arteriovenous Fistulae Lesions

The data, which were presented virtually as a podium first at the 2021 Charing Cross Symposium, demonstrated that the IN.PACT™ AV drug-coated balloon (DCB) is the first and only DCB to show sustained and superior effectiveness through two years compared to standard percutaneous transluminal angioplasty (PTA) in end-stage renal disease (ESRD) patients with de novo or non-stented restenotic native arteriovenous fistulae (AVF) in the upper extremity.

Martell Diagnostic Laboratories Announces HERTEST: Groundbreaking Way to Detect Effectiveness of Breast Cancer RX Globally

HERTEST is a blood test that looks for a protein called human epidermal growth factor receptor (HER2), which is shed into the blood stream of patients with growing breast cancer tumors.

ESPRIT CAM Improves Productivity for Long Part Machining by Automating Multi-spindle Program Creation

ESPRIT CAM: New computer-aided-manufacturing (CAM) technology has been introduced by ESPRIT CAM, part of Hexagon’s Manufacturing Intelligence division that provides manufacturers with the control and flexibility needed to use multi-spindle and multi-channel computer-numerical-control (CNC) machinery for the machining of long parts.

Vicarious Surgical reports funding was led by Philip Liang of E15 Capital.

Vicarious Surgical added Philip Liang and Ric Fulop to their Board of Directors.

“As we approach clinical use with our first product, I am thrilled to bring on Phil, E15 Capital, and the experience of their team,” said Adam Sachs, CEO of Vicarious Surgical. “Adding both the capital and E15’s experience in this industry will be invaluable to our success. This is a great milestone and a strong start to the next phase of our growth as a company.”

In addition to E15 Capital, the new round of funding includes investment from existing investors Bill Gates, Khosla Ventures, Innovation Endeavors, and AME Cloud Ventures. Vicarious Surgical plans use the proceeds to further develop its revolutionary new surgical robotics platform.

“We couldn’t be more excited to join Adam and the Vicarious Surgical team in their mission to offer high-quality surgical care across the world,” said Phillip Liang, Managing Director of E15 Capital. “I’ve been incredibly impressed with the progress the Vicarious Surgical team has made. As an investor in surgical robotics, this is the type of company and founder you hope to find. I am excited to bring our industry experience to the existing team and to drive this company towards helping patients, surgeons, and hospitals across the world.”

Ric Fulop is the founding CEO of Desktop Metal and brings his experience building two unicorn startups to the Vicarious Surgical team as a member of the Board of Directors. “I’m proud to be part of such an incredible team, and excited to help their mission to improve patient care, surgeon experience, and reduce cost from the healthcare system.”

spot_img

DON'T MISS

Related Articles